BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17022613)

  • 21. Diagnosis of treatable types of short and tall stature.
    Zachmann M
    Postgrad Med J; 1978; 54 Suppl 1():121-32. PubMed ID: 364452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Requiem for hormone replacement therapy? This does not apply to modern preparations!].
    Lippert TH; Mueck AO
    MMW Fortschr Med; 2003 Sep; 145(37):13; author reply 13-4. PubMed ID: 14584434
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of constitutional hereditary tallness with estrogens].
    Göretzlehner G; Rudolf K
    Z Arztl Fortbild (Jena); 1980 May; 74(10):465-9. PubMed ID: 7424053
    [No Abstract]   [Full Text] [Related]  

  • 25. Overgrowth.
    Verge CF; Mowat D
    Arch Dis Child; 2010 Jun; 95(6):458-63. PubMed ID: 20371592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogens reduce plasma histidine-rich glycoprotein (HRG) levels in a dose-dependent way.
    Hennis BC; Boomsma DI; Fijnvandraat K; Gevers Leuven JA; Peters M; Kluft C
    Thromb Haemost; 1995 Mar; 73(3):484-7. PubMed ID: 7667832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to investigate a child with excessive growth?
    Coutant R; Donzeau A; Decrequy A; Louvigné M; Bouhours-Nouet N
    Ann Endocrinol (Paris); 2017 Jun; 78(2):98-103. PubMed ID: 28483364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone therapy's unanswered questions.
    Harv Womens Health Watch; 2004 Jul; 11(11):1. PubMed ID: 15273055
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women.
    Murkes D; Conner P; Leifland K; Tani E; Beliard A; Lundström E; Söderqvist G
    Fertil Steril; 2011 Mar; 95(3):1188-91. PubMed ID: 21067727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pituitary gigantism].
    Tanaka T
    Nihon Rinsho; 2006 May; Suppl 1():139-42. PubMed ID: 16776112
    [No Abstract]   [Full Text] [Related]  

  • 31. Excessive growth.
    Narayanaswamy V; Rettig KR; Bhowmick SK
    Clin Pediatr (Phila); 2008 Sep; 47(7):705-8. PubMed ID: 18626098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
    Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
    [No Abstract]   [Full Text] [Related]  

  • 33. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
    Kaunitz AM;
    Medscape Womens Health; 2002; 7(4):8. PubMed ID: 12466740
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
    Skouby SO; Sidelmann JJ; Nilas L; Gram J; Jespersen J
    Climacteric; 2008; 11(6):489-97. PubMed ID: 18991076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group.
    Lobo RA; Pickar JH; Wild RA; Walsh B; Hirvonen E
    Obstet Gynecol; 1994 Dec; 84(6):987-95. PubMed ID: 7970483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of cerebral gigantism with cerebellar atrophy].
    Kitazawa K; Ikeda M; Tsukagoshi H
    Rinsho Shinkeigaku; 1990 May; 30(5):520-3. PubMed ID: 2401112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tallness and gigantism. Diagnosis and therapy].
    Pichl J; Böhles HJ
    Fortschr Med; 1986 Apr; 104(14):283-6. PubMed ID: 3710392
    [No Abstract]   [Full Text] [Related]  

  • 39. [Tall stature and its correction in girls].
    Bogdanova EA; Afonina LI
    Akush Ginekol (Mosk); 1990 Jun; (6):23-6. PubMed ID: 2221257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.